Media Press Releases Contact Us

Corbus Pharmaceuticals 2019 R&D Day

Video webcast replay now available

All SEC Filings

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
06/03/19	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
05/23/19	8-K	Current report filing			4
05/20/19	4	Statement of changes in beneficial ownership of securities			2
05/15/19	4	Statement of changes in beneficial ownership of securities			2
05/14/19	4	Statement of changes in beneficial ownership of securities			2
05/14/19	4	Statement of changes in beneficial ownership of securities			2
05/09/19	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			49
05/09/19	8-K	Current report filing Related Documents EX-99.1			14
04/29/19	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
04/18/19	8-K	Current report filing			4

1
2
3
4
5
6
7
8
9
10
...36
Next >>

Third party websites are provided for convenience only. Corbus Pharmaceuticals Holdings, Inc. does not approve of, or endorse any of the content. Corbus Pharmaceuticals Holdings, Inc. does not maintain, control or monitor the content of third party websites in any way.